Acumen Pharmaceuticals ABOS
NASDAQ ABOS
$2.02 +0.25 (+13.84%)
At close: Oct 20, 2026 · 4:00 PM EDT

Acumen Pharmaceuticals (ABOS) Notes Payables (2025 - 2026)

Updated

Acumen Pharmaceuticals (ABOS) recorded Notes Payables of $19.67 million in Q2 2026, up 39.3% from the prior quarter.

Analysis

Acumen Pharmaceuticals (ABOS) Notes Payables (2025 - 2026) Analysis & Trends

At the end of FY2025, Acumen Pharmaceuticals reported Notes Payables of $8.77 million.

  • Per Business Quant, the preceding three quarters came in at $14.12 million (Q1 2026), $8.77 million (Q4 2025) and $3.6 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn
10 Acumen Pharmaceuticals 147.03 Mn -335.04 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 19.67 Mn
Mar 31, 2026 14.12 Mn
Dec 31, 2025 8.77 Mn
Sep 30, 2025 3.60 Mn
API Access

Acumen Pharmaceuticals Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=ABOS&period=max&api_key=YOUR_API_KEY